Most lately, it has been recognized that conolidine and the above derivatives act over the atypical chemokine receptor 3 (ACKR3. Expressed in similar locations as classical opioid receptors, it binds to your big range of endogenous opioids. Contrary to most opioid receptors, this receptor functions to be a scavenger and would not activate a second